Liver fibrosis evaluation in lean steatotic liver disease patients

被引：0
|
作者：
Testino, Gianni [1 ,2 ,3 ]
机构：
[1] ASL3 Liguria, IRCCS San Martino Univ Hosp, Alcohol Reg Ctr, Unit Addict & Hepatol, Piazzale R Benzi 10, I-16132 Genoa, Italy
[2] ASL3 Liguria, Ctr Studi Mutual Self Help, Genoa, Italy
[3] ASL3, Dept Hlth Lifestyles, Genoa, Italy
来源：
MINERVA GASTROENTEROLOGY | 2024年
关键词：
D O I：
10.23736/S2724-5985.24.03686-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evaluation of liver fibrosis in patients with Wilson's disease
    Przybylkowski, Adam
    Szeligowska, Jowita
    Januszewicz, Magdalena
    Raszeja-Wyszomirska, Joanna
    Szczepankiewicz, Benedykt
    Nehring, Piotr
    Gornicka, Barbara
    Litwin, Tomasz
    Czlonkowska, Anna
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (04) : 535 - 540
  • [22] Evaluation of fibrosis in patients with nonalcoholic fatty liver disease
    Montano-Loza, Aldo J.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2022, 87 (01): : 1 - 3
  • [23] Natural history of lean and non-lean metabolic dysfunction associated steatotic liver disease
    Wakabayashi, Shun-ichi
    Tamaki, Nobuharu
    Kimura, Takefumi
    Umemura, Takeji
    Kurosaki, Masayuki
    JOURNAL OF HEPATOLOGY, 2024, 80 : S478 - S479
  • [24] Evaluation of liver fibrosis with APRI score in patients with chronic alcoholic liver disease
    Vanbiervliet, G
    Marine-Barjoan, E
    Gelsi, E
    Anty, R
    Piche, T
    Benzaken, S
    Saint-Paul, MC
    Huet, PM
    Tran, A
    JOURNAL OF HEPATOLOGY, 2005, 42 : 255 - 255
  • [25] Severe liver disease in HIV patients - Evaluation of fibrosis: liver biopsy, fibrotest
    Bailly, F
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : 4 - 6
  • [26] Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease
    Fraquelli, Mirella
    Rigamonti, Cristina
    Casazza, Giovanni
    Conte, Dario
    Donato, Maria Francesca
    Ronchi, Guido
    Colombo, Massimo
    GUT, 2007, 56 (07) : 968 - 973
  • [27] The Role of Fibroscan in Assessment of Liver Fibrosis in Patients With Diabetes Mellitus and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
    Menon, Raakhi
    Movva, Giri
    Garza, Devin
    Butt, Edward
    Zhang, Julia
    Khan, Kashif
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1240 - S1240
  • [28] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [29] Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease
    Seko, Yuya
    Lin, Huapeng
    Wong, Vincent Wai-Sun
    Okanoue, Takeshi
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [30] Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
    Vega, Luis
    Simian, Daniela
    Gajardo, Abraham I.
    Salinas, Marcelo
    Urra, Andrea
    Cattaneo, Maximo
    Pino, Rosario
    Roblero, Juan P.
    Urzua, Alvaro
    Rojas, Katherine
    Poniachik, Jaime
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
12345